FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
公司新闻(英文)
May 8, 2018 / 10:49 PM / 2 months ago

BRIEF-Opiant Pharmaceuticals Reports Q1 Loss Per Share $3.68

1 分钟阅读

May 8 (Reuters) - Opiant Pharmaceuticals Inc:

* OPIANT PHARMACEUTICALS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 LOSS PER SHARE $3.68

* QTRLY TOTAL REVENUE $1.7 MILLION VERSUS $11,000 Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below